ASX/EBR (ASX/EBR)

Australian Securities Exchange: ASX/EBR · AUD

A$0.13

+0.01 (+8.3%)· Recorded snapshot

Market cap	109.9M
Revenue (ttm)	9.3M
Net income (ttm)	-87.8M
EPS (ttm)	-A$0.19
Shares out	845.5M
Volume	1,776,431
Beta	0.50

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.3M
Net income (ttm): -87.8M
EPS (ttm): -A$0.19
Market cap: 109.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-102.5

P25 -108P50 -50.6P75 1.1

ROIC-30.8

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/EBR indicators

Market & fundamental data

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	United States
Country code	AU
Earnings date	2026-10-13
Employees	135
Enterprise value	AUD 70.5M
Exchange	Australian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2003
Industry	Medical Devices
Is primary listing	Yes
ISIN number	AU0000182552
Last earnings date	2026-07-30
Last refreshed	2026-10-30
Market cap	AUD 109.9M
Price	AUD 0.13
Price currency	AUD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-30
Symbol	asx/EBR
Website	https://www.ebrsystemsinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-146.58%
EV/Sales	6.66x
FCF / EV yield	-173.51%
FCF yield	-106.11%
P/B ratio	1.02x
P/S ratio	10.89x
Price / tangible book value	1.02x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	14.46%
Operating margin	-895.8%
Pretax margin	-942.62%
Profit per employee	AUD -650,614
Revenue per employee	AUD 69,020
ROA	-28.46%
ROA (5Y)	-30.25%
ROCE	-66.64%
ROE	-102.51%
ROE (5Y)	-139.89%
ROIC	-30.79%
SBC / revenue	57.17%
Tax / revenue	0.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	996.47%
Gross profit growth (Q)	303.53%
Net income growth years	0
Revenue growth	3,691.77%
Revenue growth (Q)	1,451.18%
Revenue growth (QoQ)	11.64%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -12.8M
Depreciation and amortization	AUD 873,872
EBIT	AUD -83.5M
EBITDA	AUD -82.6M
EPS	AUD -0.19
FCF per share	AUD -0.13
Financing cash flow	AUD 110.2M
Free cash flow	AUD -107.6M
Free cash flow minus SBC	AUD -113M
Gross profit	AUD 1.3M
Income taxes	AUD 2,891
Investing cash flow	AUD 5.4M
Net cash flow	AUD 20.8M
Net income	AUD -87.8M
Operating cash flow minus SBC	AUD -100.1M
Operating income	AUD -83.5M
Revenue	AUD 9.3M
Stock-based compensation	AUD 5.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.77
Book value per share	AUD 0.13
Debt / equity	0.87
Interest coverage	-10.56
Long-term assets	AUD 43.9M
Long-term liabilities	AUD 27M
Net cash (debt)	AUD 39.4M
Net cash / market cap	38.85%
Net cash growth	-4.04%
Net debt / equity	-0.4
Piotroski F-Score	1
Property, plant and equipment	AUD 30.2M
Shareholders' equity	AUD 99.5M
Tangible book value	AUD 99.5M
Tangible book value per share	AUD 0.13
Total assets	AUD 200.5M
Total cash	AUD 124.2M
Total debt	AUD 86.3M
Total liabilities	AUD 100.9M
WACC	7.11%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.05
Current assets	AUD 156.5M
Current liabilities	AUD 73.9M
Current ratio	2.12
Inventory turnover	0.49
Net working capital	AUD 20.9M
Quick ratio	1.71
Working capital	AUD 84M
Working capital turnover	0.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-26.89%
Shareholder yield	-26.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.38
1D price change	8.33%
1M price change	-50%
1M total return	-50%
1W price change	-3.7%
1W total return	-3.7%
1Y price change	-89.21%
1Y return CAGR	-88.49%
1Y total return	-88.48%
20-day SMA	AUD 0.16
200-day SMA	AUD 0.49
3M price change	-52.73%
3M total return	-52.73%
3Y price change	-80.15%
3Y return CAGR	-40.21%
3Y total return	-78.64%
50-day SMA	AUD 0.23
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 1.25
52-week high date	2025-10-31
52-week low	AUD 0.12
52-week low date	2026-10-30
6M price change	-78.86%
6M total return	-77.42%
All-time high	AUD 2.08
All-time high date	2025-03-24
All-time low	AUD 0.12
All-time low date	2026-10-27
Average true range (ATR)	AUD 0.02
Average volume	3.2M
Beta (1Y)	0.54
Beta (2Y)	0.53
Beta (5Y)	0.5
Change from 52-week high	-89.6%
Change from 52-week low	8.33%
Change from all-time high	-93.75%
Change from all-time low	8.33%
Change from open	4%
Day's gap	4.17%
Dollar volume	AUD 230,936
High price	AUD 0.14
Low price	AUD 0.12
Monthly RSI	30.42
Open price	AUD 0.13
Position in 52-week range	66.67%
Previous close	AUD 0.12
Price vs 150-day SMA	-65.42%
Price vs 20-day SMA	-21.12%
Price vs 200-day SMA	-73.42%
Price vs 50-day SMA	-42.96%
Relative volume	0.56
RSI	31.03
Sharpe ratio	-2.26
Sharpe ratio (3Y)	-0.45
Sortino ratio	-2.8
Sortino ratio (3Y)	-0.55
Volume	1.8M
Weekly RSI	20.29
YTD price change	-85.47%
YTD total return	-84.48%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	698.4M
Shares change (QoQ)	9.32%
Shares change (YoY)	26.89%
Shares held by insiders	0.95%
Shares held by institutions	12.37%
Shares outstanding	845.5M

Deeper analysis on ASX/EBR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/EBR report

Is a complete ASX/EBR research report available?

No complete published report is available for asx/EBR (ASX/EBR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/EBR (ASX/EBR)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/EBR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/EBR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/EBR

Frequently asked questions